Agonist Anti-CD40 Antibody Treatment Reinvigorates Neoantigen-Specific CD8 T-cells and Induces Regression of Established Tumors

Explore related products in the following collection:

Poster Abstracts - C717

Related Products

Thumbnail for Blocking LILRB signaling impedes cancer development and targets immune checkpoints

Blocking LILRB signaling impedes cancer development and targets immune checkpoints

Thumbnail for Modulating the tumor microenvironment to induce cross priming for cancer immunotherapy

Modulating the tumor microenvironment to induce cross priming for cancer immunotherapy

Thumbnail for Targeted NK cells display potent activity against glioblastoma and induce protective antitumor immunity

Targeted NK cells display potent activity against glioblastoma and induce protective antitumor immunity

Thumbnail for Breast Cancer in Nigerian Women: epidemiologic features and evaluation of the utility of serum bio-markers in disease surveillance

Breast Cancer in Nigerian Women: epidemiologic features and evaluation of the utility of serum bio-markers in disease surveillance

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.